Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Summary. Using examples predominantly drawn from study of the lymphocytic choriomeningitis virus (LCMV) model system, this review describes the mechanisms involved in control of virus infections by the cell‐mediated immune response, and some of the different strategies viruses have evolved to evade such immune clearance so that they can persist in their hosts. The important role played by the CD8+ cytotoxic lymphocyte (CTL) response in clearance of many systemic virus infections is discussed: and it is emphasized that although CD8+ CTL are classically thought of as lymphocytes which mediate lysis of virus‐infected target cells, the principal mechanism by which CD8+ T cells effect clearance of persistent and many acute virus infections via production of antiviral cytokines such as tumour necrosis factor‐α and interferon‐γ, not via destruction of virus‐producing cells. To avoid immune‐mediated clearance, viruses frequently use a combination of several different strategies. These can be grouped into mechanisms for avoiding recognition by the immune response (such as establishing latent infections, replicating in immune‐priviledged sites, down‐regulating the expression of immune recognition signals on the surface of infected cells, or undergoing antigenic variation); and mechanisms for suppressing the immune response. The latter include generalized immune suppression mechanisms, and strategies for more precisely disabling the specific immune response such as inducing tolerance or exhaustion of virus‐specific CTL. The value of understanding both immune clearance mechanisms and viral evasion strategies in the rational design of immune‐based therapies to combat persistent virus infections is discussed.

Original publication

DOI

10.1111/j.1365-2893.1997.tb00176.x

Type

Journal article

Journal

Journal of Viral Hepatitis

Publisher

Wiley

Publication Date

11/1997

Volume

4

Pages

16 - 24